Abstract
As amodel for molecular mimicry, we study patients infected with human T-lymphotropic virus type 1 (HTLV-1) who develop a neurological disease called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease with important biological similarities to multiple sclerosis (MS) (Khan et al. 2001; Levin et al. 1998, 2002a; Levin and Jacobson 1997). The study of HAM/TSP, a disease associated with a known environmental agent (HTLV-1), allows for the direct comparison of the infecting agent with host antigens. Neurological disease in HAM/TSP patients is associated with immune responses to HTLV-1-tax (a regulatory and immunodominant protein) and human histocompatibility leukocyte antigen (HLA) DRB1*0101 (Bangham 2000; Jacobson et al. 1990; Jeffery et al. 1999; Lal 1996). Recently, we showed that HAM/TSP patients make antibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNP A1), a neuron-specific autoantigen (Levin et al. 2002a).Monoclonal antibodies to tax cross-reacted with hnRNP A1, indicating molecular mimicry between the two proteins. Infusion of cross-reactive antibodies with an ex vivo system completely inhibited neuronal firing indicative of their pathogenic nature (Kalume et al. 2004; Levin et al. 2002a). These data demonstrate a clear link between chronic viral infection and autoimmune disease of the central nervous system (CNS) in humans and, we believe, in turn will give insight into the pathogenesis of MS.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Albert LJ, Inman RD (1999) Molecular mimicry and autoimmunity. N Engl J Med 341:2068–2074
Bangham CR (2000) The immune response to HTLV-I. Curr Opin Immunol 12:397–402
Bangham CR (2003) Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int J Hematol 78:297–303
Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B (2003) Human T cell leukemia virus type I-induced disease: pathways to cancer andneurodegeneration. Virology 308:1–12
Edlich RF, Arnette JA, Williams FM (2000) Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 18:109–119
Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S (1993) High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med 177:1567–1573
Gessain A, Vernant J, Maurs L, Barin F, Gout O, Calender A, The GD (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407–210
Giraudon P, Szymocha R, Buart S, Bernard A, Cartier L, Belin M, Akaoka H (2000) T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease. J Immunol 164:2718–2727
Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP, Bangham CR (2002) High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 99:3335–3341
Gran B, Hemmer B, Vergelli M, McFarland H, Martin R (1999) Molecularmimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann Neurol 45:559–567
Hollsberg P, Hafler D (1993) Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 328:1173–1182
Izumo S, Umehara F, Osame M (2000) HTLV-I-associatedmyelopathy. Neuropathology [20 Suppl]:S65–68
Jacobson S (2002) Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 186[Suppl 2]:S187–192
Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245–248
Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 96:3848–5383
Jernigan M, Morcos Y, Lee SM, Dohan FC Jr, Raine C, Levin MC (2003) IgGin brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology 60:1320–1327
Kalume F, Lee SM, Morcos Y, Callaway JC, Levin MC (2004) Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. J Neurosci Res 77:82–89
Khan RB, Bertorini TE, Levin MC (2001) HTLV-1 and its neurological complications. Neurologist 7:271–8
Krecic AM, Swanson MS (1999) hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11:363–371
Lal R (1996) J Acq Imm Def Syn Human Retro 13:S170–S178
Lal RB, Giam C.-Z, Coligan, JE, Rudolph DL (1994) J Infect Dis 169:496–503
Lang H, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart D, Bell J, Jones E, Fugger L (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3:940–3
Levin M, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chen G, Posner J, Jacobson S (1998) Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol 44:87–98
Levin M, Lehky T, Flerlage N, Katz D, Kingma D, Jaffe E, Heiss J, Patronas N, McFarland H, Jacobson S (1997) New Engl J Med 336:839–845
Levin MC, Jacobson S (1997) HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol 3:126–140
Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM (2002a) Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 8:509–513
Levin MC, Lee SM, Morcos Y, Brady J, Stuart J (2002b) Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. J Infect Dis 186:1514–1517
Martin R, McFarland H (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32:121–182
McFarlin D, Blattner WB (1991) Annu Rev Med 42:97–105
Moore G, Traugott U, Scheinberg L, Raine C (1989) Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol 26:523–530
Muller S, Boire G, Ossondo M, Ricchiuti V, Smadja D, Vernant J.-C, Ozden S (1995) IgG autoantibody response in HTLV-I-infected patients. Clin Immunol Immunopathol 77:282–290
Munro TP, Magee RJ, Kidd GJ, Carson JH, Barbarese E, Smith LM, Smith R (1999) Mutational analysis of a heterogeneous nuclear ribonucleoprotein A2 response element for RNA trafficking. J Biol Chem 274:34389–34395
Nagai M, Osame M (2003) Human T-cell lymphotropic virus type I and neurological diseases. J Neurovirol 9:228–235
Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 4:586–593
Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M (1995) HTLV-I-associatedmyelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1:50–61
Nakielny S, Dreyfuss G (1997) Curr Opin Cell Biol 9:420–429
Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S, Bangham CR (1994) The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol 68:6778–81
Noraz N, Benichou S, Madaule P, Tiollais P, Vernant J, Degranges C (1993) Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains. Virology 193:80–88
Oldstone M (1998) Molecular mimicry and immune-mediated diseases. FASEB J 12:1255–1265
Osame M (2002) Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neurovirol 8:359–364
Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987) Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 21:117–122
Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031–1032
Poeisz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77:7415–7419
Romero I, Prevost M, Perret E, Adamson P, Greenwood J, Couraud P, Ozden S (2000) Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 74:6021–6030
Rudolph DL, Coligan JE, Lal RB (1994) Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay. Clin Diagn Lab Immunol March:176–181
Saito M, Nakagawa M, Kaseda S, Matsuzaki T, Jonosono M, Eiraku N, Kubota R, Takenouchi N, Nagai M, Furukawa Y, Usuku K, Izumo S, Osame M (2004) Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 189:29–40
Shyu A-B, Wilkinson MF (2000) The double lives of shuttling mRNA binding proteins. Cell 102:135–138
Soldan S, Berti R, Salem N, Secchiero P, Flamand L, Calabresi P, Brennan M, Maloni H, McFarland H, Lin H.-C, Patnaik M, Jacobson S (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3:1394–1397
Sriram S, Stratton C, Yao S, Tharp A, Ding L, Bannan J, Mitchell W (1999) Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46:6–14
Umehara F, Itoh K, Michizono K, Abe M, Izumo S, Osame M (2002) Involvement of Fas/Fas ligand system in the spinal cords of HTLV-I-associated myelopathy. Acta Neuropathol (Berl) 103:384–90
Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M (1998) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 57:839–49
Wu E, Dickson D, Jacobson S, Raine C (1993) Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta Neuropathol 86:224–235
Wucherpfennig KW (2002) Nat Med 8:455–457
Yoshida M, Osame M, Usuku K, Matsumoto M, Igata A (1987) Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting. Lancet 1:1085–1086
Yoshioka A, Hirose G, Ueda Y, Nishimura Y, Sakai K (1993) Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J Neurol Neurosurg Psych 56:1004–7
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lee, S.M., Morcos, Y., Jang, H., Stuart, J.M., Levin, M.C. (2005). HTLV-1 Induced Molecular Mimicry in Neurological Disease. In: Oldstone, M.B. (eds) Molecular Mimicry: Infection-Inducing Autoimmune Disease. Current Topics in Microbiology and Immunology, vol 296. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30791-5_7
Download citation
DOI: https://doi.org/10.1007/3-540-30791-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25597-0
Online ISBN: 978-3-540-30791-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)